1Zander M,Madsbad S,Madsen JL,et al.Effect of 6-week course of glucagon-like peptide 1 on glycaemic control,insulin sensitivity,and b -cell function in type 2 diabetes:a parallelgroup study[J].Lancet,2002,359 (9309):824-830.
2Ahren B,Simonsson E,Larsson H,et al.Inhibition of dipeptidyl peptidase-Ⅳimproves metabolic control over a 4 -week study period in type 2 diabetes[J].Diabetes Care,2002,25(5):869-875.
3Ahren B,Gomis R,Standl E,et al.Twelve-and 52-week efficacy of the dipeptidyl peptidase-Ⅳ inhibitor LAF237 in metformin-treated patients with type 2 diabetes[J].Diabetes Care,2004,27 (12):2874-2880.
4Ahren B,Pacini G,Foley JE,et al.Improved meal-related beta -cell function and insulin sensitivity by the dipeptidyl peptidase-Ⅳ inhibitor vildagliptin in metformin-treated patients with type 2 diabetes over 1 year[J].Diabetes Care,2005,28(8):1936-1940.
5Kolterman OG,Buse JB,Fineman MS,et al.Synthetic exendin-4 (exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes[J].J Clin Endocrinol Metab,2003,88 (7):3082-3089.
6Marzban,Lucy,Park,et al.Islet amyloid polypeptide and type 2 diabetes[J].Experim Geronto1,2003,38 (5):347-351.
7Weyer C,Gottlieb A,Kim DD,et al.Pramlintide reduces postprandial glucose excursions when added to regular insulin or insulin lispro in subjects with type 1 diabetes:a dose-timing study[J].Diabates Care,2003,26 (11):3074-3079.
8Maggs DG,Fineman M,Kornstein J,et al.Pramlintide reduces postprandial glucose excursions when added to insulin lispro in subjects with type 2 diabetes:a dose-timing study[J].Diabetes Metab Res Rev,2004,20 (1):55 -60.
9Ratner RE,Dickey R,Fineman M,et al.Amylin replacement with pramlintide as an adjunct to insulin therapy improves longterm glycaemic and weight control in Type 1 diabetes mellitus:a 1-year,randomized controlled trial[J].Diabet Med,2004,21 (11):1204-1212.
10Hollander PA,Levy P,Fineman MS,et al.Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes:a 1-year randomized controlled trial[J].Diabates Care,2003,26 (3):784-790.
